Ventricular tachycardia perfusion scintigraphy with pharmacologic stress

Jump to navigation Jump to search


Ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ventricular Tachycardia from other Disorders

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

Cardiac MRI

Other Diagnostic Tests

Treatment

Medical Therapy

Electrical Cardioversion

Ablation

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ventricular tachycardia perfusion scintigraphy with pharmacologic stress On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ventricular tachycardia perfusion scintigraphy with pharmacologic stress

CDC onVentricular tachycardia perfusion scintigraphy with pharmacologic stress

Ventricular tachycardia perfusion scintigraphy with pharmacologic stress in the news

Blogs on Ventricular tachycardia perfusion scintigraphy with pharmacologic stress

to Hospitals Treating Ventricular tachycardia perfusion scintigraphy with pharmacologic stress

Risk calculators and risk factors for Ventricular tachycardia perfusion scintigraphy with pharmacologic stress

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References